Fairvalue-Calculator Fairvalue-Calculator
EN DE

Reliq Health Technologies Inc (RHT) Fair Value & Analysis

Healthcare · CA · Market cap A$19.1M

PriceA$0.0460
Fair ValueA$0.0340
Upside-26.0%
Quality95/100
Evidence: Medium Range A$0.0294 – A$0.0386

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Reliq Health Technologies Inc (RHT) currently trades at A$0.0460, while our model-based Fair Value estimate is A$0.0340 — implying the stock looks roughly 26.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.

Open the full interactive analysis →

Similar stocks

Veeva Systems Inc (VEEV) +20% Pro Medicus Limited (PME) -81% BrightSpring Health Services, Inc (BTSG) -61% Tempus AI, Inc (TEM) -74% HealthEquity, Inc (HQY) -6% M3, Inc (MTHRY) +48%

Frequently asked questions

Is Reliq Health Technologies Inc (RHT) undervalued?
As of Jun 26, 2026, our model estimates a fair value of A$0.0340 versus a price of A$0.0460 — about −26% (overvalued). Model-based estimate, not financial advice.
What is the fair value of RHT?
Our 21-model fair value for Reliq Health Technologies Inc is A$0.0340 (as of Jun 26, 2026), built from audited fundamentals. The current price is A$0.0460.
What is the quality score of RHT?
Reliq Health Technologies Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.